TuHURA Biosciences Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +128.7% | -50.4% | +70.6% | -39.2% | -20.3% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -94.0% | +3,133.3% | -97.2% | +2,817.6% | +34.9% | +15.2% | +7.5% | +0.8% | +21.9% | -13.6% | +26.5% | – | |
| – | – | – | -21.7% | +146.0% | – | – | -48.0% | +67.9% | -11.3% | +47.1% | -6.7% | – | |
| – | -65.9% | +358.7% | -48.6% | +56.3% | +53.4% | +23.6% | +40.7% | -31.9% | +21.5% | -8.2% | +16.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +432.1% | +47.5% | -73.9% | -100.0% | – | – | +3,582.3% | -95.4% | +1,571.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.